申请人:Sandoz Inc.
公开号:US03931172A1
公开(公告)日:1976-01-06
The invention discloses 1-tertiary-butyl-3-morpholino-3-phenyl-2,1-benzisoxazolines having pharmacological activity in animals and useful, for example, as hypolipidemic agents. The compounds may be prepared by reacting a 1-tertiary-butyl-3-phenyl-2,1-benzisoxazolium quaternary salt, e.g., 1-tertiary-butyl-3-phenyl-2,1-benzisoxazolium tetrafluoroborate with morpholine. The 1-tertiary-butyl-3-phenyl-2,1-benzisoxazolium quaternary salt may be prepared by reaction of a corresponding 3-phenyl-2,1-benzisoxazole with tertiary-butanol in the presence of a strong inorganic acid.
本发明揭示了1-叔丁基-3-吗啡基-3-苯基-2,1-苯并异噁唑啉,具有动物药理活性,例如作为降脂剂等有用。该化合物可通过将1-叔丁基-3-苯基-2,1-苯并异噁唑盐,例如1-叔丁基-3-苯基-2,1-苯并异噁唑四氟硼酸盐与吗啡啉反应来制备。1-叔丁基-3-苯基-2,1-苯并异噁唑盐可通过在强无机酸存在下将相应的3-苯基-2,1-苯并异噁唑与叔丁醇反应制备。